Protara Therapeutics, Inc. (TARA) Financials
TARA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 79.0 million | 10.6 million |
2023-09-30 | 88.5 million | 11.5 million |
2023-06-30 | 95.1 million | 9.9 million |
2023-03-31 | 106.4 million | 11.6 million |
TARA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -8.7 million | 1.5 million |
2023-09-30 | 128000 | 1.4 million |
2023-06-30 | -9.4 million | 1.6 million |
2023-03-31 | -12.9 million | 1.6 million |
TARA Net Income
No data available :(
TARA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 65.6 million | - | 5.5 million |
2023-09-30 | 74.0 million | - | 5.7 million |
2023-06-30 | 80.4 million | - | 5.9 million |
2023-03-31 | 86.6 million | - | 6.2 million |
TARA Shares Outstanding
TARA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 6.4 million | 4.7 million | 107000 |
2023-09-30 | 37000 | 6.2 million | 4.5 million | - |
2023-06-30 | 2000 | 7.2 million | 4.9 million | - |
2023-03-31 | 6000 | 5.1 million | 4.6 million | - |
TARA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 107000 |
2023-09-30 | - | 107000 |
2023-06-30 | - | 420000 |
2023-03-31 | - | 77000 |
TARA
Price: $2.89
52 week price:
Earnings Per Share: -3.57 USD
P/E Ratio: -0.45
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 2909
Market Capitalization: 32.5 million